IL6 and acute kidney injury: Main outcome measures included inflammatory and endothelial biomarkers (IL-6, IL-8, angiopoietin-2, syndecan-1), body fluid composition assessed by bioelectrical impedance, and clinical outcomes, including acute kidney injury (AKI), ICU length of stay (LOS), and ICU mortality.